[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349696-105":59,"doc-detail-349696-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ybx1-orchestrates-ldha-mediated-metabolic-reprogramming-and-nf-b-activation-to-drive-clear-cell-renal-cell-carcinoma-progression","YBX1 orchestrates LDHA-mediated metabolic reprogramming and NF-κB activation to drive clear cell renal cell carcinoma progression","","Y-box binding protein 1 (YBX1) is shown to regulate glycolysis-associated metabolic reprogramming in renal clear cell carcinoma. In 786-O cells, YBX1 is identified as a driver of LDHA-linked glycolytic activity, where YBX1 physically interacts with and transcriptionally controls LDHA. This YBX1-LDHA axis activates the NF-κB signaling pathway, increasing lactic acid production and promoting RCC cell proliferation. Silencing LDHA or applying an LDHA inhibitor reverses the YBX1-triggered NF-κB activation and suppresses malignant progression, suggesting a therapeutic target for RCC.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ybx1-orchestrates-ldha-mediated-metabolic-reprogramming-and-nf-b-activation-to-drive-clear-cell-renal-cell-carcinoma-progression/349696/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ybx1-orchestrates-ldha-mediated-metabolic-reprogramming-and-nf-b-activation-to-drive-clear-cell-renal-cell-carcinoma-progression/349696.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"YBX1在清除细胞肾细胞癌中的作用是什么？","Question",{"text":112,"@type":113},"YBX1在多种实验中被证实能够促进RCC的糖酵解过程，并推动恶性进展。文中指出YBX1也是RCC中显著上调的致癌因子。","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"LDHA与YBX1之间如何联系？",{"text":117,"@type":113},"研究通过机制实验表明YBX1与LDHA相互作用并在细胞质中共定位，且能够通过转录层面调控LDHA。临床组织与生物信息学结果也支持二者相关性。",{"name":119,"@type":110,"acceptedAnswer":120},"敲低LDHA或抑制LDHA会带来什么效果？",{"text":121,"@type":113},"敲低LDHA或使用LDHA抑制剂可救回YBX1介导的NF-κB通路激活，并抑制乳酸产生与RCC细胞增殖，从而减轻致癌进展。","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349696,1790441823,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nYBX1 orchestrates LDHA-mediated metabolic reprogramming and NF-κB activation to drive clear cell renal cell carcinoma progression  \nYihan Dong 1,8, Aixin Qiu2,8, Shuang Liu3,8, Yuejing Pan1, Tianyu Lin 4,5, Rui Wang1, Ruibing Chen 6, Huamao Jiang7, Yang Yu2 ✉, Yong Wang4 ✉ and Dan Yue 1 ✉  \n© The Author(s) 2025  \n|  |  |  |\n| --- | --- | --- |\n|  | Renal cell carcinoma (RCC) is sometimes referred to as a “metabolic disease”, as nearly all types of RCC are associated with thereprogramming of glucose and lipid metabolism. Y-box binding protein 1 (YBX1) plays a crucial regulatory role in the development and progression of various cancers. In the early stages of our study, we analyzed the YBX1 binding proteins in 786-O cells using IPMS and found that YBX1 is involved in the glycolysis process of RCC. Subsequent experiments showed that YBX1 is an oncogene that is signiﬁcantly upregulated in RCC. Functionally, YBX1 promotes glycolysis in RCC, and both in vitro and in vivo experiments demonstrate that YBX1 contributes to the malignant progression of RCC. The correlation between YBX1 and Lactate Dehydrogenase A (LDHA) expression was predicted by bioinformatics and further explored in clinical RCC tissues. Mechanistically, YBX1 interacts with LDHA and co-localizes in the cytoplasm. CUT&Tag and functional experiments further revealed that YBX1 regulates LDHA through transcription. Additionally, YBX1 and LDHA activate the nuclear factor kappa-B (NF-κB) signaling pathway. Silencing the LDHA gene or using an LDHA inhibitor rescued the YBX1-mediated activation of the NF-κB signaling pathway and inhibited lactic acid production and RCC cell proliferation. In conclusion, these ﬁndings provide new insights into the oncogenic |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| role of YBX1 in glycolysis and suggest that the YBX1-LDHA-NF-κB axis may represent a promising therapeutic target of RCC. |  |  |\n|  | Cell Death and Disease (2026)17:11; [https://doi.org/10.1038/s41419-025-08261-0](https://doi.org/10.1038/s41419-025-08261-0) |  |\n|  |  |  |\n\nINTRODUCTION  \nRenal cell carcinoma (RCC) is a malignant tumor originating from renal epithelium and is one of the most common tumors in the urinary system [1] . RCC accounts for more than 90% of renal malignancies, ranking second only to prostate cancer and bladder cancer among male urinary system malignant tumors [2] . Renal clear cell carcinoma (ccRCC), papillary renal cell carcinoma, and chromophobe RCC are the three most prevalent and deadly subtypes of RCC, accounting for 70–75% of all RCC cases [3] . VHL mutation is common in RCC, which usually leads to metabolic abnormalities [4, 5] . Unlike normal cells, most cancer cells generate energy through aerobic glycolysis, a phenomenon known as the “Warburg effect”, which is a key hallmark of cancer [6] . Therefore, it is urgent to explore new therapeutic targets to better understand the role of RCC metabolism and progression.  \nYBX1 is a multifunctional member of the cold shock domain protein family and is an important transcription factor. YBX1 exertsits transcriptional regulatory effects by binding to Y-box sequences located in the enhancer and promoter regions of numerous genes [7], thereby controlling the expression of genes  \nimplicated in cancer onset, progression, metastasis, and resistance to therapy. YBX1 is highly expressed in various cancers, including breast cancer [8], liver cancer [9], pancreatic cancer [10], and ovarian cancer [11] . It is signiﬁcantly associated with poor prognostic outcomes across these diseases. Thus, YBX1 has emerged as a potential therapeutic target for various types of cancer. Our previous work has demonstrated that YBX1 is highly expressed in RCC and affects its progression [12, 13] . Recent reports have shown that YBX1 is associated with metabolic reprogramming and promote","cbCaibui8qjQWUYw","https://ap.wps.com/l/cbCaibui8qjQWUYw","pdf",8792822,16,"English","# Introduction\n## Warburg effect and RCC metabolism\n## YBX1 as a transcriptional regulator in cancers\n## LDHA in aerobic glycolysis and tumor prognosis\n## Rationale for the YBX1–LDHA–NF-κB mechanism","[{\"question\":\"YBX1在清除细胞肾细胞癌中的作用是什么？\",\"answer\":\"YBX1在多种实验中被证实能够促进RCC的糖酵解过程，并推动恶性进展。文中指出YBX1也是RCC中显著上调的致癌因子。\"},{\"question\":\"LDHA与YBX1之间如何联系？\",\"answer\":\"研究通过机制实验表明YBX1与LDHA相互作用并在细胞质中共定位，且能够通过转录层面调控LDHA。临床组织与生物信息学结果也支持二者相关性。\"},{\"question\":\"敲低LDHA或抑制LDHA会带来什么效果？\",\"answer\":\"敲低LDHA或使用LDHA抑制剂可救回YBX1介导的NF-κB通路激活，并抑制乳酸产生与RCC细胞增殖，从而减轻致癌进展。\"}]","YBX1 orchestrates LDHA-mediated metabolic reprogramming and NF-κB activation to drive clear cell renal cell carcinoma progression | PDF",1790085085,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/827f1a9f7e1d190f86cb1fd488e7621d.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6064af1ea223fc46ecf1e942cbc21b0.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9cd03a522e50e4d2711553fbdcd6121b.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e4b8703cb7e1c7cbd544d3b3d282ef3d.webp",980,1301]